Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients

被引:0
|
作者
Johanna G. H. van Nes
Esther M. de Kruijf
Hein Putter
Dana Faratian
Alison Munro
Fiona Campbell
Vincent T. H. B. M. Smit
Gerrit-Jan Liefers
Peter J. K. Kuppen
Cornelis J. H. van de Velde
John M. S. Bartlett
机构
[1] Leiden University Medical Centre,Department of Surgery
[2] University Medical Centre Groningen,Department of Radiation Oncology
[3] University of Groningen,Department of Medical Statistics
[4] Leiden University Medical Centre,Department of Pathology, Endocrine Cancer Group, Edinburgh Cancer Research Centre
[5] Western General Hospital,Department of Pathology
[6] Leiden University Medical Centre,undefined
来源
Breast Cancer Research and Treatment | 2012年 / 133卷
关键词
Early breast cancer; Prognostic factors; SNAIL; SLUG; TWIST;
D O I
暂无
中图分类号
学科分类号
摘要
Epithelial mesenchymal transition (EMT) plays an important role in the development of metastases. One of the hallmarks of EMT is loss of E-cadherin and gain of N-cadherin expression, which are regulated by transcription factors, such as SNAIL, SLUG, and TWIST. We examined the prognostic value of these factors as well as E-cadherin and N-cadherin, in a well-described large cohort of breast cancer patients treated with primary surgery. Analyses were stratified by estrogen receptor (ER) status, because of its crucial role in the regulation of these transcription factors. SNAIL, SLUG, and TWIST expression were examined on a TMA containing 575 breast tumors using immunohistochemistry. Nuclear expression was quantified using a weighted histoscore and classified as high versus low expression, based on the median histoscore. High expression of SNAIL, SLUG, and TWIST was seen in 54, 50, and 50% of tumors, respectively. The level of SNAIL (P = 0.014) and TWIST (P = 0.006) expression was associated with a worse patient relapse-free period, specifically in patients with ER-positive tumors (interaction Cox proportional hazards P = 0.039). Combining both factors resulted in an independent prognostic factor with high discriminative power (both low versus either high: HR 1.15; both low versus both high HR 1.84; P = 0.010). Co-expression of SNAIL–TWIST was associated with low-E-cadherin and high-N-cadherin expression, especially in ER-positive tumors (P = 0.009), suggesting that, through interactions with ER, SNAIL and TWIST may regulate E- and N-cadherin expression, thereby inducing EMT. Our results are indicative that SNAIL and TWIST play a crucial role in EMT through regulation of E- and N-cadherin expression, exclusively in ER-positive breast cancer patients.
引用
收藏
页码:49 / 59
页数:10
相关论文
共 50 条
  • [31] Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Katsuta, Eriko
    Dasgupta, Subhamoy
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S34 - S34
  • [32] High Ezrin Expression Is Linked To Poor Prognosis and Drug Resistance in Estrogen Receptor-Positive Breast Cancer
    Vanna, Sonal
    Hoskin, Victoria
    Ghaffari, Abdi
    Madarnas, Yolanda
    SenGupta, Sandip
    Elliott, Bruce
    LABORATORY INVESTIGATION, 2015, 95 : 71A - 71A
  • [33] High Ezrin Expression Is Linked To Poor Prognosis and Drug Resistance in Estrogen Receptor-Positive Breast Cancer
    Varma, Sonal
    Hoskin, Victoria
    Ghaffari, Abdi
    Madarnas, Yolanda
    SenGupta, Sandip
    Elliott, Bruce
    MODERN PATHOLOGY, 2015, 28 : 71A - 71A
  • [34] Lewis Y EpCAM co-expression in breast cancer is correlated with poor prognosis
    Sauter, G
    Schuster, M
    Himmler, G
    Mudde, GC
    Loibner, H
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S50 - S50
  • [35] Tamoxifen induces heparanase expression in estrogen receptor - Positive breast cancer
    Cohen, Irit
    Maly, Bella
    Simon, Itamar
    Meirovitz, Amichay
    Pikarsky, Eli
    Zcharia, Eyal
    Peretz, Tamar
    Vlodavsky, Israel
    Elkin, Michael
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4069 - 4077
  • [36] The impact of CBP expression in estrogen receptor-positive breast cancer
    Wafaa S. Ramadan
    Iman M. Talaat
    Mahmood Y. Hachim
    Annette Lischka
    Timo Gemoll
    Raafat El-Awady
    Clinical Epigenetics, 2021, 13
  • [37] The impact of CBP expression in estrogen receptor-positive breast cancer
    Ramadan, Wafaa S.
    Talaat, Iman M.
    Hachim, Mahmood Y.
    Lischka, Annette
    Gemoll, Timo
    El-Awady, Raafat
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [38] Co-expression of genes with estrogen receptor-alpha and progesterone receptor in human breast carcinoma tissue
    Andres, Sarah A.
    Wittliff, James L.
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2012, 12 (01) : 377 - 390
  • [39] SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
    Alfarsi, Lutfi H.
    El Ansari, Rokaya
    Craze, Madeleine L.
    Mohammed, Omar J.
    Masisi, Brendah K.
    Ellis, Ian O.
    Rakha, Emad A.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 317 - 331
  • [40] High expression of LMTK3 is an independent factor indicating a poor prognosis in Japanese estrogen receptor α-positive breast cancer patients
    Toyama, Tatsuya
    Asano, Tomoko
    Sato, Shinya
    Yoshimoto, Nobuyasu
    Endo, Yumi
    Hato, Yukari
    Yu, Dong
    Takahashi, Satoru
    Fujii, Yoshitaka
    CANCER RESEARCH, 2015, 75